J Struct Funct Genomics
Journal of Structural and Functional Genomics
1345-711X
1570-0267
Kluwer Academic Publishers
Dordrecht


1769342
17146617
9010
10.1007/s10969-006-9010-3
Original Paper


Coverage of whole proteome by structural genomics observed through protein homology modeling database

Yura
Kei

+81-774-71-3462
+81-774-71-3460
yura.kei@jaea.go.jp

1

Yamaguchi
Akihiro

2

Go
Mitiko

2
3

1
Quantum Bioinformatics Team, Center for Computational Science and Engineering, Japan Atomic Energy Agency, 8-1 Umemidai, Kizu-cho, Souraku-gun, Kyoto, 619-0215 Japan 
2
Department of Bio-Science, Faculty of Bio-Science, Nagahama Institute of Bio-Science and Technology, 1266, Tamura-cho, Nagahama, Shiga, 526-0829 Japan 
3
Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo, 112-8610 Japan 

5
12
2006

6
2006

7
2
65
76
11
5
2006

8
8
2006


© Springer Science+Business Media B.V. 2006

http://daisy.nagahama-i-bio.ac.jp/Famsbase/
), which is based on the protein three-dimensional (3D) structures released by November 2003, contains modeled 3D structures for 368,724 open reading frames (ORFs) derived from genomes of 276 species, namely 17 archaebacterial, 130 eubacterial, 18 eukaryotic and 111 phage genomes. Those 276 genomes are predicted to have 734,193 ORFs in total and the current FAMSBASE contains protein 3D structure of approximately 50% of the ORF products. However, cases that a modeled 3D structure covers the whole part of an ORF product are rare. When portion of an ORF with 3D structure is compared in three kingdoms of life, in archaebacteria and eubacteria, approximately 60% of the ORFs have modeled 3D structures covering almost the entire amino acid sequences, however, the percentage falls to about 30% in eukaryotes. When annual differences in the number of ORFs with modeled 3D structure are calculated, the fraction of modeled 3D structures of soluble protein for archaebacteria is increased by 5%, and that for eubacteria by 7% in the last 3 years. Assuming that this rate would be maintained and that determination of 3D structures for predicted disordered regions is unattainable, whole soluble protein model structures of prokaryotes without the putative disordered regions will be in hand within 15 years. For eukaryotic proteins, they will be in hand within 25 years. The 3D structures we will have at those times are not the 3D structure of the entire proteins encoded in single ORFs, but the 3D structures of separate structural domains. Measuring or predicting spatial arrangements of structural domains in an ORF will then be a coming issue of structural genomics.

Keywords
domain duplication
domain interactions
genome
homology modeling
P-loop
structural genomics

issue-copyright-statement
© Springer Science+Business Media B.V. 2006




Introduction
2001
2000
2000
2005
2002
2003
2003
2003
2003
2006
). However, determining protein structures of all the function-unknown proteins for applying these types of study is not practical.
1972
1986
1995
2000
2001
2001
2000
2002
2000
).
2005
2005
2006
2000
2004
2003
2005
2005
2000
2000
2003
2003
).
2003
http://daisy.nagahama-i-bio.ac.jp/Famsbase/
2000
2002
).
We report here the update of the database including differences in the amount of structural data from the previous version, estimation of the time that whole ORFs predicted out of genome sequences are covered by homology modeling 3D structures and upcoming issues for utilizing those modeled structures.

Methods
Data update of FAMSBASE
2002
2004
2000
) is applied by Umeyama et al. to pair-wise alignments between a predicted ORF sequence and an amino acid sequence with known 3D structure, and a 3D structure is modeled. All the results are stored in FAMSBASE.

Assessing annual difference of data in FASBASE
2004
1998
i
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{{\rm G}i}}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{{\rm G}i}}$$\end{document}

i
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}\times100$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$_{{\rm G}i}\times100$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ \begin{aligned} \hbox{coverage of soluble protein }&=\sum\limits_{i\in {\rm kingdom}} {{\rm S3}_{{\rm G}i}} /\sum\limits_{i\in {\rm kingdom}} {{\rm S}_{{\rm G}i}}\times 100,\\ \hbox{coverage of membrane protein }&=\sum\limits_ {i\in {\rm kingdom}} {{\rm M3}_{{\rm G}i}} /\sum\limits_{i\in {\rm kingdom}} {{\rm M}_{{\rm G}i}}\times100. \end{aligned} $$\end{document}

 Both figures are calculated based on the data at the different times of FAMSBASE update, gradients in figures are then calculated, and the figures are extrapolated up to the year that coverage reaches to 100.
2005
2005
2003
) and omit these disordered regions from the calculation.

Non-overlap multiple model structures in single ORFs
2003
). Therefore, the expected number of modeled structures in the above criteria is between three and five.

Prediction of domain interfaces
i
i
b
S
b
i

I
b
i

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ I_{b,i} =-\log_2 \left({\left({S_{b,i}/\sum\limits_i{S_{b,i}} }\right)/\left({S_{0,i}/\sum\limits_i{S_{0,i}}}\right)}\right). $$\end{document}

b
I
b
i

1982
I
i

 is assigned to every residue on the surface (accessibility no less than 0.15) of a modeled 3D structure. The hydrophobicity of each residue on a surface of a protein is then obtained by averaging the assigned values of residues within 7.0 Å from the residue in concern. A hydrophobic patch on the surface of the modeled structure is found as a cluster of surface residues with the hydrophobicity no less than 0.0.


Results and discussion
Coverage of whole protein space by homology modeling
http://daisy.nagahama-i-bio.ac.jp/
1993
) and find that about 72% of the modeled 3D structures are energetically ranked as number one and comparable to experimentally determined 3D structures. Some of the structures that fail the test are structures of a part of a large protein, mostly structural domains of large proteins. It is difficult to assess the quality of this type of domain structures, because interfaces of the domain for other parts of the protein are exposed in the modeled structures. Tendency of amino acid residue appearance in the interface is supposed to be different from that at the surface as we discuss down below.
1
Table 1
Number of ORFs and those with modeled 3D structures in 276 genomes

Species
ORF
Model
%


Archaea

Archaeoglobus fulgidus
 DSM4304
2,407
1,233
51.2

Aeropyrum pernix
 K1
2,694
789
29.3

Halobacterium
 sp. NRC-1
2,605
1,195
45.9

Methanosarcina acetivorans
 C2A
4,544
2,124
46.7

Methanocaldococcus jannaschii
 DSM2661
1,770
875
49.4

Methanopyrus kandleri
 AV19
1,687
784
46.5

Methanosarcina mazei
 Goe1
3,371
1,634
48.5

Methanothermobacter thermautotrophicus

1,869
998
53.4

Nanoarchaeum equitans
 Kin4-M
536
264
49.3

Pyrococcus abyssi Orsay

1,784
942
52.8

Pyrobaculum aerophilum
 IM2
2,605
1,047
40.2

Pyrococcus furiosus
 DSM 3638
2,065
1,035
50.1

Pyrococcus horikoshii
 OT3
2,061
879
42.6

Sulfolobus solfataricus
 P2
2,994
1,365
45.6

Sulfolobus tokodaii
 7
2,826
1,228
43.5

Thermoplasma acidophilum
 DSM1728
1,478
844
57.1

Thermoplasma volcanium
GSS1
1,526
839
55.0

sum
38,822
18,075
46.6

Eubacteria

Aquifex aeolicus
 VF5
1,553
929
59.8

Nostoc
 sp. PCC 7120
6,132
2,765
45.1

Agrobacterium tumefaciens
 C58
5,301
3,017
56.9

A. tumefaciens
 C58 (Dupont)
5,402
3,028
56.1

Bacillus anthracis
 str. Ames
5,311
2,463
46.4

Buchnera aphidicola
 Sg
552
410
74.3

B. aphidicola

507
385
75.9

Bordetella bronchiseptica
 RB50
4,994
2,934
58.8

Borrelia burgdorferi

1,639
535
32.6

Bacillus cereus
 ATCC 14579
5,255
2,534
48.2

Candidatus Blochmannia floridanus

583
447
76.7

Bacillus halodurans
 C-125
4,066
2,127
52.3

Bradyrhizobium japonicum

8,317
4,449
53.5

Bifidobacterium longum
 NCC2705
1,731
985
56.9

Brucella melitensis
 16M
3,198
1,801
56.3

Bordetella parapertussis

4,185
2,525
60.3

B. pertussis
 Tohama I
3,447
2,179
63.2

Bacillus subtilis
 168
4,106
2,153
52.4

Brucella suis
 1330
3,264
1,677
51.4

Bacteroides thetaiotaomicron
 VPI-5482
4,816
2,462
51.1

Buchnera
 sp. APS
574
436
76.0

Clostridium acetobutylicum
 ATCC824
3,848
2,053
53.4

Coxiella burnetii
 RSA 493
2,045
925
45.2

Chlamydophila caviae
 GPIC
1,005
505
50.2

Caulobacter crescentus

3,737
2,084
55.8

Corynebacterium diphtheriae
 NCTC13129
2,272
1,165
51.3

Corynebacterium efficiens
 YS-314
2,998
1,513
50.5

Corynebacterium glutamicum
 ATCC 13032
3,099
1,554
50.1

Campylobacter jejuni

1,634
893
54.7

Chlamydia muridarum
 Nigg
911
483
53.0

Clostridium perfringens
 13
2,723
1,470
54.0

Chlamydophila pneumoniae
 AR39
1,116
495
44.4

Chlamydophila pneumoniae
 CWL029
1,052
496
47.1

Chlamydophila pneumoniae
 J138
1,069
501
46.9

Chlamydophila pneumoniae
 TW-183
1,113
501
45.0

Chlorobium tepidum
 TLS
2,252
1,166
51.8

Clostridium tetani
 E88
2,432
1,306
53.7

Chlamydia trachomatis
 D/UW-3/CX
894
485
54.3

Chromobacterium violaceum
 ATCC 12472
4,385
2,343
53.4

Deinococcus radiodurans
 R1
3,102
1,579
50.9

Escherichia coli
 K-12 MG1655
4,284
2,398
56.0

E. coli
 O157:H7
5,447
2,607
47.9

E. coli
 O157:H7 EDL933
5,449
2,629
48.2

E. coli
 CFT073
5,379
2,558
47.6

Enterococcus faecalis
 V583
3,265
1,568
48.0

Fusobacterium nucleatum
 ATCC 25586
2,067
1,011
48.9

Geobacter sulfurreducens
 PCA
3,445
1,902
55.2

Gloeobacter violaceus
 PCC 7421
4,430
2,208
49.8

Haemophilus ducreyi
 35000HP
1,717
865
50.4

Helicobacter hepaticus
 ATCC 51449
1,875
902
48.1

Haemophilus influenzae
 Rd
1,709
1,038
60.7

Helicobacter pylori
 26695
1,566
741
47.3

Helicobacter pylori
 J99
1,491
747
50.1

Listeria innocua
 Clip11262
3,043
1,641
53.9

Leptospira interrogans
 serovar
4,725
1,719
36.4

Lactococcus lactis
 IL1403
2,266
1,254
55.3

Listeria monocytogenes
 EGD-e
2,846
1,653
58.1

Lactobacillus plantarum
 WCFS1
3,009
1,647
54.7

Mycobacterium bovis
 subsp.
3,920
2,018
51.5

Mycoplasma gallisepticum
 R
726
371
51.1

Mycoplasma genitalium
 G37
480
305
63.5

Mycobacterium leprae
 TN
1,605
918
57.2

Mesorhizobium loti
 MAFF303099
7,281
3,829
52.6

Mycoplasma penetrans

1,037
472
45.5

Mycoplasma pneumoniae
 M129
688
333
48.4

Mycoplasma pulmonis
 UAB CTIP
782
398
50.9

Mycobacterium tuberculosis
 H37Rv
3,918
2,036
52.0

Mycobacterium tuberculosis
 CDC1551
4,187
1,990
47.5

Nitrosomonas europaea
 ATCC 19718
2,461
1,366
55.5

Neisseria meningitidis
 MC58
2,025
1,016
50.2

Neisseria meningitidis
 Z2491
2,065
1,025
49.6

Oceanobacillus iheyensis
 HTE831
3,496
1,892
54.1

Phytoplasma asteris
, OY strain
754
423
56.1

Pseudomonas aeruginosa
 PAO1
5,566
3,206
57.6

Porphyromonas gingivalis
 W83
1,909
944
49.4

Photorhabdus luminescens laumondii

4,683
2,286
48.8

Prochlorococcus marinus
 MED4
1,712
933
54.5

Prochlorococcus marinus
 MIT9313
2,265
1,122
49.5

Prochlorococcus marinus marinus

1,882
939
49.9

Pasteurella multocida
 PM70
2,014
1,237
61.4

Pseudomonas putida
 KT2440
5,350
2,968
55.5

Pseudomonas syringae
 pv. tomato str.
5,608
2,938
52.4

Pirellula
 sp. 1
7,325
2,588
35.3

Rickettsia conorii
 Malish 7
1,374
572
41.6

Rhodopseudomonas palustris

4,814
2,739
56.9

Rickettsia prowazekii
 Madrid E
834
498
59.7

Ralstonia solanacearum
 GMI1000
5,116
2,698
52.7

Streptococcus agalactiae

2,124
1,159
54.6

Streptococcus agalactiae
 NEM316
2,094
1,174
56.1

Staphylococcus aureus
 Mu50
2,748
1,451
52.8

Staphylococcus aureus
 N315
2,624
1,447
55.1

Staphylococcus aureus
 MW2
2,659
1,410
53.0

Streptomyces avermitilis

7,671
4,001
52.2

Streptomyces coelicolor
 A3(2)
8,154
4,195
51.4

Staphylococcus epidermidis
 ATCC 12228
2,485
1,303
52.4

Shigella flexneri
 2a 301
4,452
2,306
51.8

Shigella flexneri
 2a str. 2457T
4,068
2,159
53.1

Sinorhizobium meliloti
 1021
6,205
3,499
56.4

Streptococcus mutans
 UA159
1,960
1,136
58.0

Shewanella oneidensis
 MR-1
4,778
2,291
47.9

Streptococcus pneumoniae
 R6
2,094
1,101
52.6

Streptococcus pneumoniae
 TIGR4
2,043
1,135
55.6

Streptococcus pyogenes
 SF370
1,696
956
56.4

Streptococcus pyogenes
 MGAS8232
1,845
996
54.0

Streptococcus pyogenes
 MGAS315
1,865
986
52.9

Streptococcus pyogenes
 SSI-1
1,861
976
52.4

Salmonella typhi
 CT18
4,767
2,347
49.2

Salmonella typhimurium
 LT2
4,554
2,457
54.0

Salmonella enterica
 subsp. enterica
4,323
2,263
52.3

Synechocystis
 sp. PCC 6803
3,167
1,679
53.0

Synechococcus
 sp. WH 8102
2,517
1,243
49.4

Thermosynechococcus elongatus
 BP-1
2,475
1,303
52.6

Thermotoga maritima
 MSB8
1,846
1,051
56.9

Treponema pallidum
 subsp.
1,031
517
50.1

Thermoanaerobacter tengcongensis
 MB4T
2,588
1,403
54.2

Tropheryma whipplei
 TW08/27
783
494
63.1

Tropheryma whipplei
 str. Twist
808
499
61.8

Ureaplasma urealyticum

611
303
49.6

Vibrio cholerae
 N16961
3,828
1,971
51.5

Vibrio parahaemolyticus
 RIMD 2210633
4,832
2,461
50.9

Vibrio vulnificus
 CMCP6
4,537
2,461
54.2

Vibrio vulnificus
 YJ016
5,028
2,499
49.7

Wigglesworthia brevipalpis

611
441
72.2

Wolinella succinogenes
 DSMZ 1740
2,044
1,208
59.1

Xanthomonas axonopodis
 pv. citri 306
4,427
2,374
53.6

Xanthomonas campestris
 pv. campestris
4,181
2,287
54.7

Xylella fastidiosa
 9a5c
2,832
1,158
40.9

Xylella fastidiosa
 Temecula1
2,036
1,066
52.4

Yersinia pestis
 CO92
4,083
2,116
51.8

Yersinia pestis
 KIM
4,281
2,123
49.6

sum
396,126
206,311
52.1

Eukaryotes

Arabidopsis thaliana

28,723
14,394
50.1

Caenorhabditis briggsae

14,713
7,063
48.0

Caenorhabditis elegans

22,220
8,841
39.8

Ciona intestinalis

15,865
7,994
50.4

Drosophila melanogaster

18,302
9,541
52.1

Danio rerio

26,587
16,443
61.8

Encephalitozoon cuniculi

1,996
887
44.4

Guillardia theta
 Nucleomorph
632
307
48.6

Homo sapiens
 (ENSEMBLE)
28,063
15,467
55.1

Leishmania major
 Friedlin
173
62
35.8

Mus musculus

24,928
14,382
57.7

Neurospora crassa

10,088
3,800
37.7

Oryza sativa

16,724
4,517
27.0

Plasmodium falciparum
 3D7
5,268
1,905
36.2

Rattus norvegicus

28,682
16,740
58.4

Saccharomyces cerevisiae

5,869
2,913
49.6

Schizosaccharomyces pombe

5,261
2,807
53.4

Takifugu rubripes rubripes

37,452
15,202
40.6

sum
291,546
143,265
49.1

Phages/Viruses

186
46
8
17.4

44AHJD
21
1
4.8

44RR2.8t
252
51
20.2

933W
80
9
11.3

A118
72
9
12.5

A511
11
0
0.0

Aeh1
331
51
15.4

APSE-1
54
6
11.1

B1
11
1
9.1

B103
17
4
23.5

Bcep781
61
5
8.2

BF23
8
1
12.5

bIL170
64
2
3.1

bIL285
62
5
8.1

bIL286
61
7
11.5

bIL309
56
6
10.7

bIL310
29
4
13.8

bIL311
22
6
27.3

bIL312
27
3
11.1

BK5-T
63
6
9.5

Bxb1
86
12
14.0

C2
39
2
5.1

Cp-1
28
2
7.1

ϕCTX
47
4
8.5

D29
79
15
19.0

D3
94
11
11.7

Rb15
49
6
12.2

ϕg1e
49
6
12.2

GA-1
35
3
8.6

Gh-1
42
12
28.6

H-19B
22
4
18.2

HF2
114
11
9.6

HK022
57
8
14.0

HK620
58
6
10.3

HK97
61
10
16.4

HP1
41
3
7.3

HP2
36
3
8.3

K139
44
4
9.1

KVP40
381
57
15.0

2,389
57
7
12.3

L-413C
40
4
10.0

L5
85
12
14.1

λ
66
18
27.3

A2
61
8
13.1

Mu
53
6
11.3

N15
60
13
21.7

Mycoplasma virus P1
11
0
0.0

Enterobacteria phage P1
11
0
0.0

P2
42
5
11.9

P22
36
9
25.0

P27
58
9
15.5

P335
49
6
12.2

P4
12
2
16.7

P60
80
13
16.3

PA01
34
5
14.7

PaP3
69
8
11.6

ϕKZ
306
25
8.2

ϕCh1
98
9
9.2

ϕYeO3-12
59
13
22.0

ϕ105
51
8
15.7

ϕC31
55
8
14.5

ϕ3626
50
10
20.0

ϕE125
71
12
16.9

ϕETA
66
8
12.1

ϕNIH1.1
55
6
10.9

ϕPV83
65
9
13.8

ϕSLT
62
12
19.4

ϕadh
63
8
12.7

ϕBT1
55
9
16.4

ϕA1122
50
10
20.0

P68
22
2
9.1

ϕKMV
48
11
22.9

PM2
22
1
4.5

PRD1
22
4
18.2

ΨM2
31
1
3.2

ΨM100
37
4
10.8

PY54
67
10
14.9

PZA
27
4
14.8

R1t
50
6
12.0

RB69
256
56
21.9

RB49
272
49
18.0

Rd
47
6
12.8

RM378
146
17
11.6

PVL
62
8
12.9

Sfi11
25
1
4.0

V
53
7
13.2

SIO1
34
6
17.6

Sk1
54
1
1.9

SP6
20
6
30.0

SP βc2
185
33
17.8

SPP1
106
7
6.6

MM1
53
6
11.3

ST64B
56
8
14.3

ST64T
65
9
13.8

7201
46
8
17.4

DT1
47
7
14.9

O1205
57
4
7.0

Sfi19
45
6
13.3

Sfi21
50
9
18.0

Stx2
165
11
6.7

T3
44
10
22.7

T4
278
58
20.9

T7
58
10
17.2

TM4
89
5
5.6

TP901-1
56
7
12.5

Tuc2009
56
7
12.5

Ul36
58
5
8.6

VHML
57
8
14.0

VpV262
67
4
6.0

VT2-Sa
82
11
13.4

Wϕ
44
4
9.1

Sum
7,699
1073
13.9

Total
734,193
368,724
50.2





1
1
2004
2002
Fig. 1
Percentage of amino acid residues included in modeled 3D structures in each ORF is classified by 10% bins and shown in pie charts. ORFs without a modeled structure are not included. A number of ORFs with modeled structures and an average length of the ORFs are shown at the center of each pie chart. Sections bordered by thick black lines indicate that the unmodeled region in the ORF is no less than the size of a domain (about 150 residues)





Annual difference of model structures
2003
). In the current update of FAMSBASE based on data by around 2004, 42% of amino acid residues in all ORFs in archaebacterial and 46% of eubacterial genomes are included in modeled structures. In eukaryotic genomes, 24% of amino acid residues in 2003, and 26% in 2004 are included in modeled 3D structures. Those figures can be used to estimate the time when modeled 3D structures of whole proteins predicted from genomes are obtained. The estimation for the time obtaining the whole soluble and membrane proteins are treated separately, because the speed of structure determination for soluble and membrane proteins seems to differ. The assumption for the estimation is that the speed for structure determination would stay the same and no new protein family would appear.
1998
2001
2003
2
Fig. 2
Annual differences of modeled structures classified by kingdoms of life. The percentage is the number of amino acid residues included in modeled structures over the whole number of residues in predicted sequences for soluble and membrane proteins in each kingdom. (S) stands for soluble proteins and (M) stands for membrane proteins. Some of the residues are predicted to be in a disordered region. The percentage of residues in disordered regions is shown at the top




1999
2
, the figures are around 40% in 1999, indicating that their figures approximately lie on the extrapolated lines.
2004
2005
2003
2004
2004
2005
), and therefore we will not linearly extrapolate the present status to estimate the due day for membrane proteins.

Frequency of template structure in use
2002
2
2
2
HC zinc fingers’ superfamilies, which appear specifically in eukaryotic genomes, follow the top.
3
2000
2
2
2
Fig. 3
Frequency of template usage in descending order. Horizontal axis is a template and the vertical axis is a frequency of templates in use. Red line is a template usage in archaebacteria, blue line is eubacteria and green line is eukaryotes




2003
4
Fig. 4
Protein family distribution of ‘P-loop containing nucleoside triphosphate hydrolases’ superfamily in each kingdom. In the three pie charts, the section with the same color is a category of the same family except for the white section




2
2
2
2004
2005
2005
Table 2
Top 15 modeling templates in the newly determined 3D structures between 2002 and 2003

PDBID
Chain
Number of uses as a template
a

Protein name


1q12
A
7,031
N
Maltose/maltodextrin transport ATP-binding protein MalK

1l2t
A
6,529
N
Hypothetical ABC transporter ATP-binding protein Mj0796

1oxx
K
3,948
N
ABC transporter ATP-binding protein GlcV

1pf4
A
3,202
N
Transport ATP-Binding Protein MsbA

1nr0
A
2,640
Y
Actin interacting protein 1 Aip1

1ixc
A
2,495
N
LysR-type regulatory protein CbnR

1ld8
A
2,410
N
Farnesyltransferase α subunit

1ji0
A
2,331
Y
ABC transporter

1oyw
A
2,251
N
ATP-dependent DNA helicase; RecQ helicase

1kt1
A
2,198
N
Fk506-binding protein FKBP51

1mt0
A
1,961
N
Haemolysin secretion ATP-binding protein; ATP-binding domain

1mdb
A
1,745
N
2,3-dihydroxybenzoate-AMP ligase DhbE

1nnm
A
1,730
N
Acetyl-CoA synthetase

1gxr
A
1,715
N
Transducin-like enhancer protein 1 Esg1

1uoh
A
1,706
N
26S proteasome non-ATPase regulatory subunit 10



a 
PDB entry seemingly derived from the SG projects judged by description in PDB file is tagged Y, and the remaining entry is tagged N




Whole structure and function of proteins from homology modeling of domain structures
2003
2004
1
1996
2005
2003
2003
).”
5
Escherichia coli
Pyrococcus abyssi
E. coli
2004
E. coli
E. coli
Fig. 5
Eukaryotic ORFs with multiple model structures covering more than 70% of entire protein. In each of the bar representation of proteins, a black box is a region with 3D structure. A name and PDB ID of a template structure and amino acid sequence identity between template and target domains are given below the black box. A yellow box is a putative signal peptide and green box is a putative transmembrane region. Template and modeled structures of ENSMUSP00000019416 were shown on the right side of the figure. Each domain is colored by hydrophobicity. A hydrophilic residue is in green and a hydrophobic residue is in red. A buried residue is in deep blue




2002
5
. One of the template structures, Nkp46 ectodomain, has hydrophilic surface (green) around the C-terminal residues of the domain, however the modeled structure has a hydrophobic surface (orange) at the corresponding area. The other template structure, LIR-1 D1D2, has a hydrophilic surface around the N-terminal residues of the domain, however the modeled structure has a hydrophobic surface at the corresponding area. The surfaces uniquely turned into hydrophobic in modeled structures are close to the residues that are chemically bonded in the target protein, and therefore both of the areas likely form interfaces of the two domains. The modeled structure based on LIR-1 D1D2 domain has another hydrophobic surface around the C-terminal residues, which may interact with CD158j-like domain located at the C-terminal side of the domain.

Accuracy of homology modeling
2005
2004
2001
2003
6
6
2003
2005
Fig. 6
Distribution of sequence identity between template and target amino acid sequences in FAMSBASE






Conclusion
Construction of database of whole genome homology modeling clarified that protein 3D structures of about 50% of the protein coding regions in whole genome can now be modeled. Maintaining the current speed of 3D structure determination, it will take, at most, 11 years to have enough templates to cover whole soluble proteins of eubacterial genomes, and 25 years to cover those of eukaryotic genomes. The current advancement in technologies of protein structure determination is expected to make these due times closer to the present. What we obtain at those times are not the 3D structures of entire proteins, but domain structures in pieces. A homology modeled domain structure is now in use of predicting domain functions, but predicting spatial arrangement of domains in a protein will be an important issue for function prediction.


Acknowledgements
This work was supported by a Grant-in-Aid for Scientific Research on Priority Area (C), Genome Information Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

References
Andreeva
A

Howorth
D

Brenner
SE

Hubbard
TJP

Chothia
C

Murzin
AG


Nucleic Acids Res
2004
32
D22
10.1093/nar/gkh039

Andreeva A, Howorth D, Brenner SE, Hubbard TJP, Chothia C, Murzin AG (2004) Nucleic Acids Res 32:D22 

Baker
D

Sali
A


Science
2001
294
93
10.1126/science.1065659

11588250


Berman
HM

Westbrook
J

Feng
Z

Gilliland
G

Bhat
TN

Weissig
H

Shindyalov
IN

Bourne
PE


Nucleic Acids Res
2000
28
235
10.1093/nar/28.1.235

10592235


Brenner
SE


Nat Struct Biol
2000
7
Suppl
967
10.1038/80747

11104002


Burley
SK


Nat Struct Biol
2000
7
Suppl
932
10.1038/80697

11103991


Burley
SK

Bonanno
JB


Annu Rev Genomics Hum Genet
2002
3
243
10.1146/annurev.genom.3.022502.103227

12194989


Campbell
SJ

Gold
ND

Jackson
RM

Westhead
DR


Curr Opin Struct Biol
2003
13
389
10.1016/S0959-440X(03)00075-7

12831892


Chandonia
J-M

Brenner
SE


Science
2006
311
347
10.1126/science.1121018

16424331


Chothia
C

Lesk
AM


EMBO J
1986
5
823

3709526


Contreras-Moreira
B

Ezkurdia
I

Valencia
TA


FEBS lett
2005
579
1203
10.1016/j.febslet.2005.01.014

15710414


Contreras-Moreira
B

Fitzjohn
PW

Bates
PA


J Mol Biol
2003
328
593
10.1016/S0022-2836(03)00309-7

12706719


Copley
RR

Ponting
CP

Schultz
J

Bork
P


Adv Protein Chem
2002
61
75

12461821


Dayhoff
MO


Atlas of protein sequence and structure, vol 5
1972
Washington, DC
National Biomedical Research, Foundation Georgetown University

Dayhoff MO (1972) Atlas of protein sequence and structure, vol 5. National Biomedical Research, Foundation Georgetown University, Washington, DC 

DeLucas
LJ

Hamrick
D

Cosenza
L

Nagy
L

McCombs
D

Bray
T

Chait
A

Stoops
B

Belgovskiy
A

William Wilson
W


Prog Biophys Mol Biol
2005
88
285
10.1016/j.pbiomolbio.2004.07.008

15652246


Dobrovetsky
E

Lu
ML

Andorn-Broza
R

Khutoreskaya
G

Bray
JE

Savchenko
A

Arrowsmith
CH

Edwards
AM

Koth
CM


J Struct Funct Genomics
2005
6
33
10.1007/s10969-005-1363-5

15909233


Domingues
FS

Koppensteiner
WA

Sippl
MJ


FEBS Lett
2000
476
98
10.1016/S0014-5793(00)01678-1

10878259


Doolittle
RF


Annu Rev Biochem
1995
64
287
10.1146/annurev.bi.64.070195.001443

7574483


Dyson
HJ

Wright
PE


Nat Rev Mol Cell Biol
2005
6
197
10.1038/nrm1589

15738986


Editorial Board

Nat Struct Mol Biol
2004
11
201
10.1038/nsmb0304-201

14983166


Goldsmith-Fischman
S

Honig
B


Protein Sci
2003
12
1813
10.1110/ps.0242903

12930981


Hirokawa
T

Boon-Chieng
S

Mitaku
S


Bioinformatics
1998
14
378
10.1093/bioinformatics/14.4.378

9632836


Iwadate
M

Ebisawa
K

Umeyama
H


Chem-Bio Infor J
2001
1
136
10.1273/cbij.1.136

Iwadate M, Ebisawa K, Umeyama H (2001) Chem-Bio Infor J 1:136 

John
B

Sali
A


Nucleic Acids Res
2003
31
3982
10.1093/nar/gkg460

12853614


Kawabata
T

Fukuchi
S

Homma
K

Ota
M

Araki
J

Ito
T

Ichiyoshi
N

Nishikawa
K


Nucleic Acids Res
2002
30
294
10.1093/nar/30.1.294

11752318


Kim
S-H

Shin
DH

Choi
I-G

Schulze-Gahmen
U

Chen
S

Kim
R


J Struct Funct Genomics
2003
4
129
10.1023/A:1026200610644

14649297


Kim
S-H


Curr Opin Struct Biol
2000
10
380
10.1016/S0959-440X(00)00100-7

10851198


Kinoshita
K

Nakamura
H


Curr Opin Struct Biol
2003
13
396
10.1016/S0959-440X(03)00074-5

12831893


Koonin
EV

Aravind
L

Kondrashov
AS


Cell
2000
101
573
10.1016/S0092-8674(00)80867-3

10892642


Kopp
J

Schwede
T


Nucleic Acids Res
2004
32
D230
10.1093/nar/gkh008

14681401


Krogh
A

Larsson
B

Heijne
G

Sonnhammer
EL


J Mol Biol
2001
305
567
10.1006/jmbi.2000.4315

11152613


Kyogoku
Y

Fujiyoshi
Y

Shimada
I

Nakamura
H

Tsukihara
T

Akutsu
H

Odahara
T

Okada
T

Nomura
N


Acc Chem Res
2003
36
199
10.1021/ar0101279

12641477


Kyte
J

Doolittle
RF


J Mol Biol
1982
157
105
10.1016/0022-2836(82)90515-0

7108955


Laskowski
RA

Watson
JD

Thornton
JM


J Struct Funct Genomics
2003
4
167
10.1023/A:1026127927612

14649301


Laskowski
RA

Luscombe
NM

Swindells
MB

Thornton
JM


Protein Sci
1996
5
2438

8976552


Leipe
DD

Koonin
EV

Aravind
L


J Mol Biol
2003
333
781
10.1016/j.jmb.2003.08.040

14568537


Lichtarge
O

Sowa
ME


Curr Opin Struct Biol
2002
12
21
10.1016/S0959-440X(02)00284-1

11839485


Linding
R

Jensen
LJ

Diella
F

Bork
P

Gibson
TJ

Russell
RB


Structure
2003
11
1453
10.1016/j.str.2003.10.002

14604535


Liu
G

Li
Z

Chiang
Y

Acton
T

Montelione
GT

Murray
D

Szyperski
T


Protein Sci
2005
14
1597
10.1110/ps.041322705

15930006


Lo Conte
L

Brenner
SE

Hubbard
TJ

Chothia
C

Murzin
AG


Nucleic Acids Res
2002
30
264
10.1093/nar/30.1.264

11752311


Lundstrom
K


Curr Opin Drug Discov Devel
2004
7
342

15216938


Marti-Renom
MA

Stuart
AC

Fiser
A

Sanchez
R

Melo
F

Sali
A


Annu Rev Biophys Biomol Struct
2000
29
291
10.1146/annurev.biophys.29.1.291

10940251


McPherson
A


J Struct Funct Genomics
2004
5
3
10.1023/B:JSFG.0000029199.43875.92

15263838


Ogata K, Umeyama H (2000) J Mol Graph Model 18:258

Oldfield
CJ

Ulrich
EL

Cheng
Y

Dunker
AK

Markley
JL


Proteins
2005
59
444
10.1002/prot.20446

15789434


Orengo
CA

Pearl
FM

Bray
JE

Todd
AE

Martin
AC

Lo Conte
L

Thornton
JM


Nucleic Acids Res
1999
27
275
10.1093/nar/27.1.275

9847200


Ota
M

Kinoshita
K

Nishikawa
K


J Mol Biol
2003
327
1053
10.1016/S0022-2836(03)00207-9

12662930


O’Toole
N

Raymond
S

Cygler
M


J Struct Funct Genomics
2003
4
47
10.1023/A:1026156025612

14649288


Petrey
D

Honig
B


Mol Cell
2005
20
811
10.1016/j.molcel.2005.12.005

16364908


Pieper
U

Eswar
N

Davis
FP

Braberg
H

Madhusudhan
MS

Rossi
A

Marti-Renom
M

Karchin
R

Webb
BM

Eramian
D

Shen
M-Y

Kelly
L

Melo
F

Sali
A


Nucleic Acids Res
2006
34
D291
10.1093/nar/gkj059

16381869


Serre
V

Penverne
B

Souciet
JL

Potier
S

Guy
H

Evans
D

Vicart
P

Herve
G


BMC Biochem
2004
5
6
10.1186/1471-2091-5-6

15128434


Service
R


Science
2005
307
1554
10.1126/science.307.5715.1554

15761136


Sippl
MJ


Proteins Struct Func Genet
1993
17
355
10.1002/prot.340170404

Sippl MJ (1993) Proteins Struct Funct Genet 17:355 

Stark
A

Shkumatov
A

Russell
RB


Structure (Camb)
2004
12
1405
10.1016/j.str.2004.05.012

15296734


Stein
L


Nat Rev Genet
2001
2
493
10.1038/35080529

11433356


Todd
AE

Marsden
RL

Thornton
JM

Orengo
CA


J Mol Biol
2005
348
1235
10.1016/j.jmb.2005.03.037

15854658


Tsoka
S

Ouzounis
CA


FEBS Letters
2000
480
42
10.1016/S0014-5793(00)01776-2

10967327


Vitkup
D

Melamud
E

Moult
J

Sander
C


Nat Struct Biol
2001
8
559
10.1038/88640

11373627


Walian
P

Cross
T

Jap
B


Genome Biol
2004
5
215
10.1186/gb-2004-5-4-215

15059248


Wallace
IM

Blackshields
G

Higgins
DG


Curr Opin Struct Biol
2005
15
261
10.1016/j.sbi.2005.04.002

15963889


Wodak
SJ

Janin
J


Adv Protein Chem
2002
61
9

12461820


Xie
L

Bourne
PE


PLoS Comput Biol
2005
1
e31
10.1371/journal.pcbi.0010031

16118666


Yamaguchi
A

Iwadate
M

Suzuki
E

Yura
K

Kawakita
S

Umeyama
H

Go
M


Nucleic Acids Res
2003
31
463
10.1093/nar/gkg117

12520053


Yokoyama
S

Hirota
H

Kigawa
T

Yabuki
T

Shirouzu
M

Terada
T

Ito
Y

Matsuo
Y

Kuroda
Y

Nishimura
Y

Kyogoku
Y

Miki
K

Masui
R

Kuramitsu
S


Nat Struct Biol
2000
7
Suppl
943
10.1038/80712

11103994





